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would increase the conﬁdence of decision makers regarding the
continuation of the new model.
Outcomes items used in the decision: Evaluation outcomes for
1568 patients were analysed that included appropriateness, efﬁ-
ciency, effectiveness, cost and cost-effectiveness, safety, and
access. The analyses compared the outcomes of the new contin-
uum to the current standard of care. Due to the randomized con-
trolled designed approach, the analyses were not confounded by
patient or regional biases.
Implementation Strategy: Within each region a new pre- and
post-operative clinic along with dedicated operating rooms and
inpatient beds were established to implement and test the new
continuum. To avoid the risk of contamination, these newly
established facilities were physically separated from the current
way. The new care path included clinical pathways that were
developed and implemented to train the health care providers to
adhere to the new continuum. Agreed by all pilot partners, data
were systematically collected, evaluated, and used to compare
the current system to the new continuum to enhance appropri-
ate decision making about potential province-wide adaptation of
the new model. This evaluation required ethical approval and
individual patient consent.
Results: Results from the randomized control trial demonstrated
that the new model was signiﬁcantly more efﬁcient, more effec-
tive, and more cost effective (on a cost per patient basis) than
the current system. No difference in safety outcomes at three
months post-surgery were seen between intervention and control
patient groups. Results also highlighted implementation chal-
lenges with a change project of this scale particularly as this
relates to changes in the behaviour of patients and of providers
across the continuum of care.
Lessons Learned: Through the development and implementation
of the new continuum, we learned that: 1) advancement of a
provincial approach required inclusion of all partners involved
in the delivery of care (e.g., physicians, health care providers,
decision makers, government), and 2) evidence was not only key
to designing a new continuum, but also required as proof of
concept and ongoing system monitoring and improvement.
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Problem or Issue Addressed: Reducing unnecessary immuniza-
tion of US Army recruits through cost-effective serologic screen-
ing to assess pre-existing immunity.
Goals: US Army recruits receive multiple vaccines, including
hepatitis A, hepatitis B, measles, mumps, and rubella (MMR),
and varicella vaccine upon military accession. In April, 2004, the
Defense Health Board (formerly the Armed Forces Epidemio-
logical Board), a scientiﬁc advisory body to the Assistant Secre-
tary of Defense for Health Affairs and the military Surgeons
General, recommended that the military services implement sero-
logic screening of recruits where feasible to reduce unnecessary
immunizations. The goal of this analysis was to develop an eco-
nomic and clinical outcomes model that would inform immu-
nization policy decisions. The model compared two screening
approaches: the existing policy of no universal screening; and
universal screening for a subset of disease immunity (hepatitis A,
hepatitis B, measles, rubella, and varicella antibodies).
Outcome items used in the decision: In October, 2004, a detailed
cost-effectiveness model was developed. The model inputs
included vaccine costs, serologic screening costs, rates of immu-
nity, and the sensitivity and speciﬁcity of the serologic screening
tests. The model predicted marginal serologic screening costs,
vaccine cost savings per recruit, and the mean number of vacci-
nations per recruit. The model estimated that, over its ﬁrst six
years, the Accession Screening and Immunization Program
(ASIP) would avert the unnecessary administration of approxi-
mately $40 million of vaccine and eliminate one million unnec-
essary injections in US Army recruits with serologic evidence of
immunity.
Implementation Strategy: A pilot study at a single Military Treat-
ment Facility (MTF) evaluating serologic screening of recruits
demonstrated its feasibility and cost-saving potential. Concur-
rently, a detailed business plan was developed to expand the
program to all ﬁve MTFs serving US Army basic combat train-
ing sites, and to internally redistribute anticipated marginal cost
savings at each MTF to fund the ﬁxed infrastructure, equipment,
and civilian staff required to implement and sustain the program.
A newly created Program Management Ofﬁce (PMO) at the Mil-
itary Vaccine Agency was established to coordinate implementa-
tion, audit program functional requirements, and conduct
economic analyses to validate outcomes research model predic-
tions. The US Army Surgeon General approved Army-wide
program implementation in November, 2005.
Results: One year after the implementation of the ASIP, prelim-
inary results conﬁrm that vaccine cost savings exceed the mod-
erate costs of implementing local screening programs. The ASIP
PMO is currently performing an economic analysis to quantify
the actual cost savings from averted immunizations.
Lessons Learned: The ASIP sites overcame perceived and exist-
ing barriers to implementing serologic screening through the use
of dedicated serologic testing platforms, improved electronic
medical records keeping, and the hiring of a civilian staff. Accu-
rate documentation of immunizations and serologic immunity
codes is critical for ensuring soldiers do not receive unnecessary
immunizations later in their military career, and for performing
economic analyses. Efforts are underway to enhance and inte-
grate data systems, as automatic data transfer between systems
improves data quality, timeliness, and accuracy. The establish-
ment of a centralized ASIP Program Management Ofﬁce pro-
motes implementation activities and procedural standardization
across the ﬁve Army basic combat training sites that administer
recruit immunizations. The ASIP demonstrates that health care
decisions are enhanced by economic and clinical predictions
made possible through outcomes research modeling.
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Problem or Issue Addressed: The addition of targeted therapies
to standard cancer treatments contributes greatly to increasing
hospital budgets. As part of our formulary management process,
we conducted and presented an economic analysis of beva-
cizumab in combination with standard.
Goal: The purpose of this project was to incorporate cost effec-
tiveness considerations into the Pharmacy and Therapeutics
Committee’s deliberations about the addition of a new product
to the MDACC formulary.
Outcomes items used in the decision: The institutional cost-
effectiveness analysis was conducted using direct medical costs,
